Advertisement

Shire to announce double digit earnings growth for 2012

Irish-based pharmaceuticals company Shire is expected to report 'double digit' earnings growth for 2012 on Wednesday.

Irish-based pharmaceuticals company Shire is expected to report 'double digit' earnings growth for 2012 on Wednesday.

Angus Russell, Chief Executive Officer of Shire, will unveil the company's results when he addresses investors at the JP Morgan Healthcare Conference in San Francisco at 11:00 local time.

"Shire is now increasingly confident of meeting current consensus earnings expectations for 2013," the company said in a statement issued yesterday,after the close of trading.

Advertisement - Article continues below

Russell will soon step down after 32 years with the company.

Flemming Ornskov will take over on April 30th following a hand-over period.

"I've enjoyed every day of my time at Shire. I'm very pleased to have been a part of the growth story of this excellent company and to be leaving it in such great shape for further success," Russell had said in last October's announcement of his retirement.

"I'm delighted to hand the leadership over to such a talented and visionary individual. I'll continue to watch the progress of this outstanding organisation in the years ahead."

Shire advanced 1.48% to 1,991.00p ahead of Russell's address and on news the company had acquired Lotus Tissue Repair for an undisclosed sum.

Shire is expected to gain on the acquisition of Lotus, which is focused on developing the first treatment for dystrophic epidermolysis bullosa (DEB), a rare genetic disorder that causes extremely fragile skin and recurrent blister formation.

RD

Advertisement
Advertisement

Recommended

Visit/investments/investment-strategy/601044/broker-safety-your-questions-answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
Visit/investments/investment-strategy/600861/how-demographics-affects-stock-valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Visit/investments/stocks-and-shares/600863/sirius-minerals-anglo-american-takeover
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Visit/investments/stockmarkets/600634/why-investors-should-be-cautiously-bullish-for-2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Visit/investments/property/601606/house-prices-crash-uk-property-prices-falling-where-next
Property

House price crash: UK property prices are falling – so where next?

With UK property prices falling for the first time in eight years, are we about to see a house price crash? John Stepek looks at what’s behind the sli…
2 Jul 2020
Visit/economy/inflation/601584/the-end-of-the-bond-bull-market-and-the-return-of-inflation
Inflation

The end of the bond bull market and the return of inflation

Central bank stimulus, surging post-lockdown demand and the end of the 40-year bond bull market. It all points to inflation, says John Stepek. Here’s …
30 Jun 2020
Visit/investments/stockmarkets/601611/nasdaq-all-time-high-markets-and-the-real-economy
Stockmarkets

How can markets hit new record highs when the economy is in such a mess?

Despite the world being in the midst of a global pandemic, America's Nasdaq stock index just hit an all-time high. And it's not the only index on a bu…
3 Jul 2020